Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model

• Main Authors: Emma G. Foster (Author), Brady Sillman (Author), Yutong Liu (Author), Micah Summerlin (Author), Vikas Kumar (Author), Balasrinivasa R. Sajja (Author), Adam R. Cassidy (Author), Benson Edagwa (Author), Howard E. Gendelman (Author), Aditya N. Bade (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The World Health Organization has recommended dolutegravir (DTG) as a preferred first-line treatment for treatment naive and experienced people living with human immunodeficiency virus type one (PLWHIV). Based on these recommendations 15 million PLWHIV worldwide are expected to be treated with DTG r...